The time‐varying cardiovascular benefits of glucagon‐like peptide‐1 receptor agonist therapy in patients with type 2 diabetes mellitus: Evidence from large multinational trials-Reference-Cited by-同舟云学术

The time‐varying cardiovascular benefits of glucagon‐like peptide‐1 receptor agonist therapy in patients with type 2 diabetes mellitus: Evidence from large multinational trials

Published:2022-05-23 Issue:8 Volume:24 Page:1607-1616
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Deo Salil V.¹²³^ORCID,Marsia Shayan⁴,McAllister David A.¹,Elgudin Yakov²³,Sattar Naveed⁵^ORCID,Pell Jill P.¹

Affiliation:

1. Institute of Health and Wellbeing University of Glasgow Glasgow UK

2. Surgical Services Louis Stokes Cleveland VA Medical Center Cleveland Ohio USA

3. Case School of Medicine Case Western Reserve University Cleveland Ohio USA

4. Department of Internal Medicine Dow Medical College Karachi Pakistan

5. Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14738

Reference38 articles.

1. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

2. Global Prevalence of Diabetes

3. The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

4. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

5. More Than 7 Years of Hindsight: Revisiting the FDA’s 2008 Guidance on Cardiovascular Outcomes Trials for Type 2 Diabetes Medications

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review;Journal of Medical Internet Research;2023-12-08

2. Validating the SMART2 Score in a Racially Diverse High‐Risk Nationwide Cohort of Patients Receiving Coronary Artery Bypass Grafting;Journal of the American Heart Association;2023-11-07

3. Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?;Journal of Diabetes;2023-09

4. Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review (Preprint);2023-07-21

5. Particulate Matter Air Pollution and Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention;JACC: Advances;2023-05